NFKB1 and cancer: Moreover, it has been reported that PKCζ acts as an antiapoptotic factor reducing cancer cell sensitivity to chemotherapeutic treatment [269,270] and is possibly implicated in linking cancer-related inflammation and chemoresistance via NF-kB activation and nuclear translocation [271].